Lord Venky Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 16-12-2024
- Paid Up Capital ₹ 90.00 K
as on 16-12-2024
- Company Age 35 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.07 Cr
as on 16-12-2024
- Satisfied Charges ₹ 1.43 Cr
as on 16-12-2024
- Revenue -16.85%
(FY 2023)
- Profit -312.48%
(FY 2023)
- Ebitda -58.40%
(FY 2023)
- Net Worth -24.54%
(FY 2023)
- Total Assets -10.25%
(FY 2023)
About Lord Venky Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 90.00 K .
The company currently has active open charges totaling ₹1.07 Cr. The company has closed loans amounting to ₹1.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Siva Chittoory and Ratna Chittoory serve as directors at the Company.
- CIN/LLPIN
U24232PY1989PTC000626
- Company No.
000626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Company Details
- Location
Pondicherry, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lord Venky Pharma Pvt Ltd offer?
Lord Venky Pharma Pvt Ltd offers a wide range of products and services, including Split Air Conditioners, Blue Star Split Air Conditioners, Inverter Air Conditioners, Split Inverter Air Conditioner.
Who are the key members and board of directors at Lord Venky Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratna Chittoory  | Director | 16-Apr-2016 | Current |
| Siva Chittoory | Director | 12-Mar-2020 | Current |
Financial Performance of Lord Venky Pharma.
Lord Venky Pharma Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.85% decrease. The company also saw a substantial fall in profitability, with a 312.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lord Venky Pharma?
In 2023, Lord Venky Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Agam And Gem Life Sciences LlpActive 6 years 11 monthsSiva Chittoory and Ratna Chittoory are mutual person
- Satyarath Realtors Private LimitedActive 17 years 1 month
Siva Chittoory and Ratna Chittoory are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 Apr 2015 | ₹1.07 Cr | Open |
Bank Of India Creation Date: 17 Jun 2000 | ₹0.10 M | Satisfied |
State Bank Of India Creation Date: 01 Dec 1999 | ₹2.45 M | Satisfied |
How Many Employees Work at Lord Venky Pharma?
Lord Venky Pharma has a workforce of 4 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lord Venky Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lord Venky Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
